SP

Sonia Poli

Dimerix Limited | Non-Executive Director
Dr Poli is a R&D professional with 20 years international experience in large and small pharmaceutical companies. Sonia is currently serving as advisor for several late-stage drug development projects approaching market authorization. Sonia was formerly Executive Manager at AC Immune,Nasdaq listed company, and Chief Scientific Officer at Minoryx and Addex Therapeutics and she has previously worked within Swiss Stock Exchange listed companies Hoffman la Roche.

Company and Role

Company
Title
Tenure
Since
DXB
DXB
Dimerix Limited
  • Non-Executive Director
9yrs, 9mthJul 2015

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DXB
DXB
Dimerix Limited
21/10/24559,702N/A373,835N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DXB
DXB
Dimerix Limited
21/10/24
Issued
300,000$0.367$110,148Employee Share Ownership Plan
DXB
DXB
Dimerix Limited
25/07/24
Exercise
167,202$0.400$66,880Exercise of options
DXB
DXB
Dimerix Limited
25/07/24
Buy
167,202$0.400$66,880Exercise of options
DXB
DXB
Dimerix Limited
10/04/24
Expiry
37,500$0.305$11,437Options expired
DXB
DXB
Dimerix Limited
26/03/24
Exercise
12,501$0.126$1,575Exercise of options